In our study, the absence of measurable TP53 loss-potentiated AR signal suggests that at least in these experimental models during the limited period of assays, AR-mediated proliferation was not a major factor in facilitating the propagation of TP53-deficient tumor cells. Here, TP53 is linked to neoplasm.